CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Patient Input and Clinical Experts: Vonvendi

Published on: January 2, 2020
Result type: News

CADTH has received the following notice(s) of pending drug submission(s).

Brand name Vonvendi
Generic name von Willebrand Factor [recombinant]
Manufacturer Shire Pharma Canada ULC, now part of Takeda
Indication(s) von Willebrand disease, adults, treatment and perioperative management
Project Number ST0639-000
Call for patient input 2020-01-02
Patient input deadline 2020-02-21
Submit patient input Submit
Register as Clinical Expert Register